Patient Advocacy and the United States Congress
Geno Merli, MD

Patient Advocacy and the British Parliament
Ajay K. Kakkar, MD

Human Alerts vs. Electronic Alerts
Karen Fiumara, PharmD

Anticoagulation Armamentarium: Update on Drugs and Mechanisms
Sudha Parasuraman, MD

Outpatient Treatment of VTE
Sylvia McKean, MD

Hospital Pharmacists and DVT Prevention During Hospitalization at the Time of Hospital Discharge: a Patient Safety Issue
John Fanikos, RPh, MBA

Implications of an Out-of-Range INR: Bleeding and Clotting Complications
Elaine Hylek, MD

Warfarin Genetics and Dosing: the New Pharmacogenomic Frontier
Samuel Z. Goldhaber, MD

Substituting Generic Drugs for Brand Name Drugs
Jawed Fareed, PhD

Breakout Sessions:

How to Run an Anticoagulation Service (Erin Oliver, PA-C; Mary Kay Kleinschmidt, PA-C; Cheryl Silva, PharmD; Nicole Grasso-Correnti, RN, BSN)

Knowledge is Power: Patient Advocacy (Samuel Z.Goldhaber, MD; Ruth B. Morrison, RN; Tom Hogan; Michael Hefron; Lisa Kory)

VTE Prevention: Making the Evidence Based Guidelines "Come Alive" and Transitioning from Voluntary Adherence to Mandatory Enforcement (Sylvia McKean, MD; John Fanikos, RPh, MBA)